MOLECULAR MARKERS OF BLADDER CANCER: FROM THE PARTICULAR TO THE GENERAL

Cover Page

Cite item

Full Text

Abstract

Bladder cancer (BC) is the second most common urinary tract malignancy. Early diagnosis of BC generally increases the probability of successful treatment in a patient. The paper considers noninvasive diagnosis methods for BC and gives a database of the known molecular markers of this disease.

About the authors

A. A. Zabolotneva

Acad. M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow

Email: anton@humgen.siobc.ras.ru
Russian Federation

N. M. Gaifullin

Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University

Email: anton@humgen.siobc.ras.ru
Russian Federation

A. A. Buzdin

Acad. M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow

Author for correspondence.
Email: anton@humgen.siobc.ras.ru
Russian Federation

B. Ya. Alekseyev

P.A. Herzen Moscow Oncology Research Institute

Email: anton@humgen.siobc.ras.ru
Russian Federation

Yu. Yu. Andreyeva

P.A. Herzen Moscow Oncology Research Institute

Email: anton@humgen.siobc.ras.ru
Russian Federation

P. V. Shegai

P.A. Herzen Moscow Oncology Research Institute

Email: anton@humgen.siobc.ras.ru
Russian Federation

D. G. Sokov

Moscow City Oncology Dispensary

Email: anton@humgen.siobc.ras.ru
Russian Federation

I. G. Rusakov

P.A. Herzen Moscow Oncology Research Institute

Email: anton@humgen.siobc.ras.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36986 от  21.07.2009.